Quantus

SPDR S&P Biotech ETF

XBI-US · NYSE Amex
$147.01-2.94%
2026-07-31 close
Loading chart…
Close
AI Insight

Why these signals fired — only backtest-proven edge, told honestly

Why this signalSignal guide

Moving-average alignment
No

No active signal.

Explore this stock further
Review signal, financial and filing context in chat
Explore in chat →

Strong-buy signal — the real recordrecord · not a prediction

Not this one stock, but every strong-buy pick we actually published (US market). When this stock flashes the signal, it is treated by the same rule.(as of 2026-08-03)

Last 30 sessions
759 picks
Next-day win rate
58.8%
Avg next-day
+0.55%
vs market
+0.45%p

Beat the market on 57.6% of picks (each pick vs its own day’s market average).

Recent publish days (next-day win rate)
07-30 27.3%07-29 30.8%07-28 11.1%07-27 50%07-24 28.6%07-23 44.4%07-22 50%07-21 60%07-20 33.3%07-17 37.5%07-16 16.7%07-15 50%
This stock flashed this signal 2 times over the last ~2 years (see the signal history below for each date).

Entry is the latest close at publish time; next-day is the following close. “Market” is the equal-weighted average of every stock in the same market that day; delisted names are excluded from both. Fees, taxes and slippage are not included. An observed record over a short window, not a pre-registered backtest. Not investment advice.

Financial safety

Reference indicatorAs of 2014
Safe zoneFinancial-metric reference signal
Altman Z'' zoneZ'' 3.39
Distress
Grey
Safe
The marker shows the current Z'' value within the displayed zones.
Altman Z''
3.39
Beneish M-Score
-0.98

Statistical manipulation-risk signal

Sloan accrual
0.00%

부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.

Factual information, not investment advice.

Earnings quality · Piotroski F-Score

5/9Moderate

Piotroski measures year-over-year financial improvement, not absolute quality.

Financial improvement score5/9

Profitability

  • Positive ROAPass
  • Positive OCFPass
  • Improving ΔROAPass
  • Accruals (OCF > net income)Not passed

Leverage & liquidity

  • Lower debtNot passed
  • Higher current ratioNot passed
  • No new sharesPass

Efficiency

  • Higher gross marginNot passed
  • Higher asset turnoverPass

Calculation note: F7(신주)은 equity/asset 유지로 근사

Already-stable companies may score lower when year-over-year improvement is limited.

Factual information, not investment advice.

Forensic signals

Anomaly and structural signals observed in the financial statements.

Margin trendWarning

영업외손익 급변 (영업이익 대비 2399% 규모 변동) — 일회성 손익 주의. 통계적 정황 신호이며 회계부정 단정이 아닙니다.

Factual information, not investment advice.

Risk sensitivity — adverse assumptions

Metric changes under stated assumptions; not a forecast or investment advice.

Base metrics

Operating margin
70.5%
Interest coverage
0x
Return on equity (ROE)
30.8%

Operating margin −5pp

Interest coverage risk
Interest coverageBase 0x adverse case 0x
Return on equity (ROE)Base 30.8% adverse case -29.2%

Revenue −15%

Interest coverage risk
Interest coverageBase 0x adverse case 0x
Return on equity (ROE)Base 30.8% adverse case -29.3%

Interest rate +2pp

Interest coverage risk
Interest coverageBase 0x adverse case 0x
Return on equity (ROE)Base 30.8% adverse case -29.7%

Interest coverage limit

Already below the limit by 2,483.7pp

Interest coverage limit at an operating margin of 2,554.2%

Interest expense coverage threshold

Financials at a glance

SPDR S&P Biotech ETF's latest results and balance sheet. The bars track the last three periods.

📦 ETFs holding this stock

by weight · top-10 constituents basis

Passive money holding this stock ≈ $15M(lower bound — top-10 basis, not a forecast)

Factual holdings info from daily disclosures — not a recommendation.

Look up another stock →

Recent filings

Filings for overseas stocks are on the way. For now we cover Korean stocks only.

Signal history (last ~2 years)

Every occurrence on this stock, with the return 20 trading days later. Small sample — a record, not a prediction.

Strong buy (52w high + volume)×2
26-06-22+5.9%26-06-17+10.8%
52-week high breakout×12
26-07-09·26-07-07·26-07-06·26-07-02-8.4%26-06-30-6.5%26-06-29-5.4%26-06-26-3.1%26-06-25-0.7%26-06-24+1.7%26-06-23+3.5%26-06-22+5.9%26-06-18+7.4%
New MA alignment×2
26-06-15+14.6%26-05-27+12.9%

“·” = fewer than 20 trading days since the event. Cup-and-handle entries are days our board actually showed the badge (archive grows daily since 2026-05-12); others are recomputed from price data.

Like these rules? Run them automatically.

Quantus turns rules like these into backtests and automated trading — same team, free to start.

Quantus Signal · live data · not investment advice · Privacy Policy